Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Cash from Financing Activities (2019 - 2022)

Inventiva (IVEVF) posted Cash from Financing Activities of $14.2 million for Q4 2022, down 2.22% on a QoQ basis from $14.6 million in Q3 2022, and up 40038.88% year-over-year from N/an in Q4 2021.

Analysis

Inventiva (IVEVF) Cash from Financing Activities (2019 - 2022) Analysis & Trends

Inventiva has reported Cash from Financing Activities for 4 years, with the latest figure at $14.2 million in Q4 2022.

  • On a quarterly basis, Cash from Financing Activities rose 40038.88% year-over-year to $14.2 million in Q4 2022; TTM through Dec 2022 was $24.6 million, a 16.38% decrease from a year earlier, with the FY2025 full-year figure at $280.9 million, up 80.53% from the prior year.
  • Cash from Financing Activities was $14.2 million for Q4 2022 at Inventiva, down from $14.6 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $29.3 million in Q4 2020, with the low at -$4.2 million in Q2 2021.
  • Average Cash from Financing Activities over 4 years is $9.5 million, with a median of $11.0 million recorded in 2020.
  • The sharpest annual moves came in 2021 and 2022: Cash from Financing Activities slumped 138.5% in 2021, then jumped 40038.88% in 2022.
  • Over 4 years, Cash from Financing Activities stood at -$132826.5 in 2019, then soared by 22187.97% to $29.3 million in 2020, then plunged by 99.88% to $35463.1 in 2021, then surged by 40038.88% to $14.2 million in 2022.
  • The last three Cash from Financing Activities figures came in at $14.2 million (Q4 2022), $14.6 million (Q3 2022), and $35463.1 (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn -8.78 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn -5.05 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn -2.02 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn -3.66 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -2.10 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn - 2.42 Bn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 65.46 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 122.40 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 14.23 Mn
Sep 22, 2022 14.56 Mn
Dec 31, 2021 35,463.10
Jun 30, 2021 -4.23 Mn
Mar 31, 2021 4.27 Mn
Dec 31, 2020 29.34 Mn
Jun 30, 2020 10.99 Mn
Mar 31, 2020 16.15 Mn
Dec 31, 2019 -132,826.52